Psychedelic Science 2023

Be Part of

        the Breakthrough

Presented by

Regulatory considerations and opportunities


Regulatory considerations and opportunities

Research using psychedelic drugs for therapeutic purposes has faced a number of regulatory obstacles unlike other treatments in the mental health field, including widespread skepticism and unfamiliarity among policymakers and regulators, limited government funding, and of course, Schedule 1 restrictions. In this panel, leaders of government and regulatory affairs offices from the psychedelic industry will share their stories about working with policymakers and administrators, and share their predictions for the future.

Share: Regulatory considerations and opportunities


Already Registered?

If you already registered for the in-person portion of the Psychedelic Science 2023 conference, get immediate access to PS2023: The Virtual Trip by logging in with the email address you used when signing up for the conference. We’ll email you a login link—no password necessary!

Need to Register?

If you are not yet registered for Psychedelic Science 2023, you can sign up for PS2023: The Virtual Trip access by creating an account.